Literature DB >> 28840307

Quantification of perfusion reduction by using 2D-perfusion angiography following transarterial chemoembolization with drug-eluting beads.

Sabine K Maschke1, Thomas Werncke1, Roman Klöckner2, Thomas Rodt1, Julius Renne1, Martha M Kirstein3, Arndt Vogel3, Frank K Wacker1, Bernhard C Meyer1, Jan B Hinrichs4,5.   

Abstract

PURPOSE: To analyze the feasibility of 2D-perfusion angiography (2D-PA) for the quantification of perfusion reduction following transarterial chemoembolization with drug-eluting beads (DEB-TACE).
METHODS: Overall, 24 DEB-TACE procedures in 19 patients were included. To quantify changes in tumor perfusion following DEB-TACE using 2D-PA, the acquired digital subtraction angiography (DSA) series were post-processed. A reference region-of-interest (ROI) in a main hepatic artery and two, distal target ROIs in embolized tumor tissue and in non-target liver parenchyma were placed in corresponding areas on DSA pre- and post-DEB-TACE. The time to peak (TTP), peak density (PD), and the area under the curve (AUC) were assessed and the ratios reference ROI/target ROIs were calculated.
RESULTS: In the embolized tumor, the 2D-PA ratios changed significantly (p < 0.05) after DEB-TACE, whereas no significant change was observed for non-target liver parenchyma (p > 0.05). PDtumor/PDinflow differed significantly to PDparenchyma/PDinflow pre-DEB-TACE (p < 0.0001), likewise AUCtumor/AUCinflow to AUCparenchyma/AUCinflow (p < 0.0001) with higher values in tumor tissue. The post-DEB-TACE ratios of AUC decreased significantly in the tumor tissue compared to the non-target liver parenchyma (p < 0.05).
CONCLUSION: 2D-PA offers an objective approach to quantify the immediate perfusion reduction of embolized tumor tissue following DEB-TACE and may therefore be used to monitor peri-interventional stasis and to quantify technical success.

Entities:  

Keywords:  2D-perfusion angiography; Digital subtraction angiography; Drug-eluting beads; Drug-eluting beads transarterial chemoembolization; Hepatocellular carcinoma; Transarterial chemoembolization

Mesh:

Year:  2018        PMID: 28840307     DOI: 10.1007/s00261-017-1296-z

Source DB:  PubMed          Journal:  Abdom Radiol (NY)


  5 in total

1.  2D-perfusion angiography for intra-procedural endovascular treatment response assessment in chronic mesenteric ischemia: a feasibility study.

Authors:  Annette Thurner; Anne Marie Augustin; Thorsten Alexander Bley; Ralph Kickuth
Journal:  BMC Med Imaging       Date:  2022-05-16       Impact factor: 2.795

2.  Three-dimensional regions-of-interest-based intra-operative four-dimensional soft tissue perfusion imaging using a standard x-ray system with no gantry rotation: A simulation study for a proof of concept.

Authors:  Katsuyuki Taguchi; Thomas J Sauer; W Paul Segars; Eric C Frey; Jingyan Xu; Eleni Liapi; J Webster Stayman; Kelvin Hong; Ferdinand K Hui; Mathias Unberath; Yong Du
Journal:  Med Phys       Date:  2020-10-22       Impact factor: 4.071

3.  Non-occlusive mesenteric ischemia (NOMI): evaluation of 2D-perfusion angiography (2D-PA) for early treatment response assessment.

Authors:  Lena S Becker; Klaus Stahl; Timo C Meine; Christian von Falck; Bernhard C Meyer; Cornelia L A Dewald; Nina Rittgerodt; Markus Busch; Sascha David; Frank Wacker; Jan B Hinrichs
Journal:  Abdom Radiol (NY)       Date:  2020-10

4.  Evaluation of perfusion changes using a 2D Parametric Parenchymal Blood Flow technique with automated vessel suppression following partial spleen embolization in patients with hypersplenism and portal hypertension.

Authors:  Timo C Meine; Sabine K Maschke; Martha M Kirstein; Elmar Jaeckel; Becker S Lena; Thomas Werncke; Cornelia L A Dewald; Frank K Wacker; Bernhard C Meyer; Jan B Hinrichs
Journal:  Medicine (Baltimore)       Date:  2021-02-19       Impact factor: 1.817

5.  2D-Perfusion Angiography Using Carbon Dioxide (CO2): A Feasible Tool to Monitor Immediate Treatment Response to Endovascular Therapy of Peripheral Arterial Disease?

Authors:  Cornelia L A Dewald; Lena S Becker; Sabine K Maschke; Timo C Meine; Bernhard C Meyer; Frank K Wacker; Jan B Hinrichs
Journal:  Cardiovasc Intervent Radiol       Date:  2020-12-16       Impact factor: 2.740

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.